Clinical features of diabetes mellitus with the mitochondrial DNA 3243 (A-G) mutation in Japanese: maternal inheritance and mitochondria-related complications.

Diabetes mellitus with the mitochondrial DNA 3243(A-G) mutation is reported to represent 0.5-2.8% of the general diabetic population. Since the characterization of diabetes with the mutation is still incomplete, we undertook a nation-wide case-finding study of genetically defined patients using questionnaires in Japan. One hundred and thirteen Japanese diabetic patients with the mutation were registered and analyzed. The patients had a high prevalence of maternal inheritance of diabetes and deafness, short and thin stature, and showed an early middle-aged onset of diabetes and deafness. Eighty-six percent of the patients required insulin therapy due to the progressive insulin secretory defect. Glucose intolerance of the mothers was associated with an early middle-aged onset of diabetes, reduction in the insulin secretory capacity, early requirement of insulin therapy, and increases in the daily insulin dose. The heteroplasmic concentrations of the 3243 mutation in leukocytes were low and declined with aging. The patients had advanced microvascular complications, and mitochondria-related complications such as cardiomyopathy, cardiac conductance disorders, neuromuscular symptoms, neuropsychiatric disturbance, and macular pattern dystrophy. Thus, this study has revealed that: (1) diabetes mellitus with the 3243 mutation is a subtype of diabetes mellitus with mitochondria-related complications; and (2) insulin secretory ability is more severely impaired in the patients whose mothers were glucose intolerance.

[1]  P. Froguel,et al.  Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNA Leu(UUR) gene , 1994, Diabetes.

[2]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[3]  K. Polonsky,et al.  Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. , 2000, The Journal of clinical investigation.

[4]  Y. Yazaki,et al.  The high prevalence of the diabetic patients with a mutation in the mitochondrial gene in Japan. , 1994, The Journal of clinical endocrinology and metabolism.

[5]  P. de Knijff,et al.  Heteroplasmy levels of a mitochondrial gene mutation associated with diabetes mellitus decrease in leucocyte DNA upon aging , 1996, Human mutation.

[6]  T. Asano,et al.  Clinical relevance of heteroplasmic concentration of mitochondrial A 3243 G mutation in leucocytes , 1999, Diabetologia.

[7]  H. Gin,et al.  Maternally Inherited Diabetes and Deafness: A Multicenter Study , 2001, Annals of Internal Medicine.

[8]  H. Ueno,et al.  Cardiac abnormalities in diabetic patients with mutation in the mitochondrial tRNA(Leu(UUR)) gene. , 1999, Japanese circulation journal.

[9]  J. Alcolado,et al.  Importance of maternal history of non-insulin dependent diabetic patients. , 1991, BMJ.

[10]  J. Maassen,et al.  Maternally Inherited Diabetes and Deafness: A Diabetic Subtype Associated with a Mutation in Mitochondrial DNA , 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[11]  A. Hattersley,et al.  Pigmentary retinal dystrophy and the syndrome of maternally inherited diabetes and deafness caused by the mitochondrial DNA 3243 tRNA(Leu) A to G mutation. , 1999, Ophthalmology.

[12]  K. Kaga,et al.  Auditory Findings in Patients with Maternally Inherited Diabetes and Deafness Harboring a Point Mutation in the Mitochondrial Transfer RNALeu (UUR) Gene , 1996, The Laryngoscope.

[13]  M M Shi,et al.  Enabling large-scale pharmacogenetic studies by high-throughput mutation detection and genotyping technologies. , 2001, Clinical chemistry.

[14]  S. Nagataki,et al.  Pancreatic beta-cell secretory defect associated with mitochondrial point mutation of the tRNALEU(UUR) gene: a study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) , 1994, Diabetologia.

[15]  K. Majamaa,et al.  Demyelinating polyneuropathy in a patient with the tRNALeu(uur) mutation at base pair 3243 of the mitochondrial DNA , 1995, Neurology.

[16]  K. Ohkubo,et al.  Mitochondrial gene mutations in the tRNA(Leu(UUR)) region and diabetes: prevalence and clinical phenotypes in Japan. , 2001, Clinical chemistry.

[17]  M. King,et al.  Polyneuropathy in the mtDNA base pair 3243 point mutation , 1996, Neurology.

[18]  Y. Akanuma,et al.  Prevalence of chronic complications in Japanese diabetic patients. , 1994, Diabetes research and clinical practice.

[19]  G. Matthijs,et al.  MACULAR PATTERN DYSTROPHY IN PATIENTS WITH DEAFNESS AND DIABETES , 1997, Retina.

[20]  M. Buchalter,et al.  Identification of mtDNA Mutation in a Pedigree with Gestational Diabetes, Deafness, Wolff-Parkinson-White Syndrome and Placenta accreta , 2000, Human Heredity.

[21]  K. Tsuchiya,et al.  Prevalence of A-to-G mutation at nucleotide 3243 of the mitochondrial tRNALeu(UUR) gene in Japanese patients with diabetes mellitus and end stage renal disease , 2001, Journal of Human Genetics.

[22]  D. Turnbull,et al.  Maternally inherited diabetes and deafness: prevalence in a hospital diabetic population , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[23]  Y. Yazaki,et al.  Molecular and histological evaluation of pancreata from patients with a mitochondrial gene mutation associated with impaired insulin secretion. , 1999, Biochemical and biophysical research communications.

[24]  K. Gerbitz,et al.  Mitochondrial diabetes mellitus: a review. , 1995, Biochimica et biophysica acta.

[25]  I. Rapin,et al.  Non-Mendelian mitochondrial inheritance as a cause of progressive genetic sensorineural hearing loss. , 1994, International journal of pediatric otorhinolaryngology.

[26]  R. Gill-Randall,et al.  Maternal transmission of diabetes , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[27]  J. Maassen,et al.  Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness , 1992, Nature Genetics.

[28]  A. Hattersley,et al.  UKPDS 21: Low Prevalence of the Mitochondrial Transfer RNA gene (tRNA Leu(UUR)) Mutation at Position 3243bp in UK Caucasian Type 2 Diabetic Patients , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[29]  C. Lindgren,et al.  High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes , 1999, Diabetologia.

[30]  R. Sakuta,et al.  A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. , 1994, The New England journal of medicine.

[31]  J. Maassen,et al.  Maternally inherited diabetes and deafness: a new diabetes subtype , 1996, Diabetologia.

[32]  H. Gin,et al.  Prevalence of macular pattern dystrophy in maternally inherited diabetes and deafness. GEDIAM Group. , 1999, Ophthalmology.

[33]  H. Cheong,et al.  Hereditary glomerulopathy associated with a mitochondrial tRNALeu gene mutation , 1999, Pediatric Nephrology.

[34]  S. Miyabayashi,et al.  Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation. , 2001, Kidney international.

[35]  I. Nonaka,et al.  A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies , 1990, Nature.

[36]  H. Kitaoka,et al.  A patient with diabetes mellitus, cardiomyopathy, and a mitochondrial gene mutation: confirmation of a gene mutation in cardiac muscle. , 1995, Diabetes research and clinical practice.

[37]  T. Kigoshi,et al.  Mitochondrial DNA mutations are associated with both decreased insulin secretion and advanced microvascular complications in Japanese diabetic subjects. , 1999, Journal of diabetes and its complications.

[38]  M. Miyata,et al.  Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. , 1995, Circulation.